Wells Fargo lowered the firm’s price target on Hamilton Lane (HLNE) to $161 from $166 and keeps an Equal Weight rating on the shares. The firm says that recent strength set a high bar, and Q4 was not as bad as the stock reaction, though seeing through some noisy elements was a challenge. Yet, decelerating fee AUM and unclear FRPR path might lead investors to “wait and see,” Wells adds.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLNE:
- Hamilton Lane Reports Strong Fiscal Year 2025 Results
- Hamilton Lane Inc. Reports Robust Growth Amid Challenges
- Hamilton Lane’s Adjusted EPS Boost Masks Underlying Weaknesses, Justifying Sell Rating
- Hamilton Lane reports Q4 adjusted EPS $1.21, consensus $1.17
- HLNE Earnings Report this Week: Is It a Buy, Ahead of Earnings?
